Associations of lower urinary tract symptoms with prostate-specific antigen levels, and screen-detected localized and advanced prostate cancer: A case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study

BJU International

Volumn 102, Issue 10, 2008, Pages 1400-1406

  Collin, Simon M ^a   Metcalfe, Chris ^a   Donovan, Jenny ^a   Lane, J Athene ^a   Davis, Michael ^a   Neal, David ^b   Hamdy, Freddie ^c   Martin, Richard M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

LUTS; Prostate cancer; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FAMILY HISTORY; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; NOCTURIA; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; UNITED KINGDOM; URINARY FREQUENCY; URINARY HESITANCY; URINARY URGENCY; URINE INCONTINENCE;

AGED; BIOPSY; EPIDEMIOLOGIC METHODS; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROSTATISM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 54949140002     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07817.x     Document Type: Article

References (26)

1. Brown CT, O'Flynn E, Van Der Meulen J, Newman S, Mundy AR, Emberton M. The fear of prostate cancer in men with lower urinary tract symptoms: should symptomatic men be screened? BJU Int 2003 91 : 30 2
2. Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I. High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia. Am J Med 1998 104 : 517 25
3. Rai T, Clements A, Bukach C, Shine B, Austoker J, Watson E. What influences men's decision to have a prostate-specific antigen test? A qualitative study. Fam Pract 2007 24 : 365 71
4. Filella X, Molina R, Ballesta AM, Gil MJ, Allepuz C, Rioja LA. Value of PSA (prostate-specific antigen) in the detection of prostate cancer in patients with urological symptoms. Results of a multicentre study. Eur J Cancer 1996 32A : 1125 8
5. Eastham JA, Riedel E, Scardino PT et al. Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. JAMA 2003 289 : 2695 700
6. Thorpe A, Neal D. Benign prostatic hyperplasia. Lancet 2003 361 : 1359 67
7. Catalona WJ, Partin AW, Slawin KM et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 1998 279 : 1542 7
8. Young JM, Muscatello DJ, Ward JE. Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence. BJU Int 2000 85 : 1037 48
9. Hamilton W, Sharp DJ, Peters TJ, Round AP. Clinical features of prostate cancer before diagnosis: a population-based, case-control study. Br J Gen Pract 2006 56 : 756 62
10. Porter CR, Latchamsetty KC, Coogan CL, Kim J. Absence of lower urinary tract symptoms is an independent predictor for cancer at prostate biopsy, but prostate-specific antigen is not: results from a prospective series of 569 patients. Clin Prostate Cancer 2005 4 : 50 4
11. Nam RK, Toi A, Klotz LH et al. Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer. Can J Urol 2006 13 (Suppl. 2 2 10
12. Nam RK, Toi A, Klotz LH et al. Assessing individual risk for prostate cancer. J Clin Oncol 2007 25 : 3582 8
13. Blanker MH, Groeneveld FP, Thomas S, Prins A, Bohnen AM, Bosch JL. Prostate cancer detection in older men with and without lower urinary tract symptoms: a population-based study. J Am Geriatr Soc 2003 51 : 1041 2
14. Matsubara A, Yasumoto H, Teishima J et al. Lower urinary tract symptoms and risk of prostate cancer in Japanese men. Int J Urol 2006 13 : 1098 102
15. Frankel S, Smith GD, Donovan J, Neal D. Screening for prostate cancer. Lancet 2003 361 : 1122 8
16. Donovan JL, Peters TJ, Abrams P, Brookes ST, de la Rosette JJ, Schafer W. Scoring the short form ICSmaleSF questionnaire. International Continence Society. J Urol 2000 164 : 1948 55
17. Avery KN, Blazeby JM, Lane JA, Neal DE, Hamdy FC, Donovan JL. Decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised trial. Eur Urol 2008 53 : 1186 93
18. Catalona WJ, Richie JP, Ahmann FR et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men. J Urol 1994 151 : 1283 90
19. Jakobsson L, Loven L, Hallberg IR. Micturition problems in relation to quality of life in men with prostate cancer or benign prostatic hyperplasia: comparison with men from the general population. Cancer Nurs 2004 27 : 218 29
20. Hochberg DA, Armenakas NA, Fracchia JA. Relationship of prostate-specific antigen and prostate volume in patients with biopsy proven benign prostatic hyperplasia. Prostate 2000 45 : 315 9
21. Porter CR, Kim J. Low AUA symptom score independently predicts positive prostate needle biopsy: results from a racially diverse series of 411 patients. Urology 2004 63 : 90 4
22. Ben-Shlomo Y, Evans S, Ibrahim F et al. The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study. Eur Urol 2008 53 9 105
23. Punglia RS, D'Amico AV, Catalona WJ, Roehl KA, Kuntz KM. Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level. Cancer 2006 106 : 1507 13
24. Haese A, Graefen M, Noldus J, Hammerer P, Huland E, Huland H. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia. J Urol 1997 158 : 2188 92
25. Stamey TA, Caldwell M, McNeal JE, Nolley R, Hemenez M, Downs J. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol 2004 172 : 1297 301
26. Sciarra A, Di Silverio F, Salciccia S, Autran Gomez AM, Gentilucci A, Gentile V. Inflammation and chronic prostatic diseases: evidence for a link? Eur Urol 2007 52 : 964 72